Hexosamine Pathway Is Responsible for Inhibition by Diabetes of Phenylephrine-Induced Inotropy

Diabetes

Volumn 53, Issue 4, 2004, Pages 1074-1081

  Pang, Yi ^a   Bounelis, Pam ^a   Chatham, John C ^b   Marchase, Richard B ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [2 [4 (4 NITROBENZYLOXY)PHENYL]ETHYL]ISOTHIOUREA METHANESULFONATE; ADENYLATE CYCLASE; AZASERINE; BETA ADRENERGIC RECEPTOR; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; GLUCOSAMINE; HEXOSAMINE; INOSITOL TRISPHOSPHATE; INOTROPIC AGENT; ISOPRENALINE; PHENYLEPHRINE; PHOSPHOLIPASE C; SFK 96365; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CALCIUM TRANSPORT; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; HEART; HEART MUSCLE CELL; HYPERGLYCEMIA; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOPLASMIC RETICULUM;

ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; DIABETES MELLITUS, EXPERIMENTAL; ENDOPLASMIC RETICULUM; GLUCOSAMINE; HEART RATE; HEXOSAMINES; IMIDAZOLES; INOSITOL 1,4,5-TRISPHOSPHATE; MALE; MYOCARDIAL CONTRACTION; PHENYLEPHRINE; PHOSPHOLIPASE C; RATS; RATS, SPRAGUE-DAWLEY; SARCOPLASMIC RETICULUM; VENTRICULAR FUNCTION, LEFT;

EID: 1842579981     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.4.1074     Document Type: Article

References (51)

1. Raman M, Nesto RW: Heart disease in diabetes mellitus. Endocrinol Metab Clin North Am 25:425-438, 1996
2. Rockman HA, Koch WJ, Lefkowitz RJ: Seven-transmembrane-spanning receptors and heart function. Nature 415:206-212, 2002
3. Vila Petroff MG, Aiello EA, Palomeque J, Salas MA, Mattiazzi A: Subcellular mechanisms of the positive inotropic effect of angiotensin II in cat myocardium. J Physiol (Lond) 529:189-203, 2000
4. Liu SJ, Kennedy RH: α1-Adrenergic activation of L-type Ca current in rat ventricular myocytes: perforated patch-clamp recordings. Am J Physiol 274:H2203-H2207, 1998
5. Molkentin JD, Dorn GW 2nd: Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 63:391-426, 2001
6. 2+ exchanger. J Mol Cell Cardiol 33:1861-1869, 2001
7. 2+ signalling and the generation of arrhythmias in rat atrial myocytes. J Physiol 541:395-409, 2002
8. Xiang Y, Kobilka BK: Myocyte adrenoceptor signaling pathways. Science 300:1530-1532, 2003
9. Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A, Nadal-Ginard B, Anversa P: Myocardial cell death in human diabetes. Circ Res 87:1123-1132, 2000
10. Fiordaliso F, Leri A, Cesselli D, Limana F, Safai B, Nadal-Ginard B, Anversa P, Kajstura J: Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 50:2363-2375, 2001
11. Kamata K, Satoh T, Tanaka H, Shigenobu K: Changes in electrophysiological and mechanical responses of the rat papillary muscle to alpha- and beta-agonist in streptozotocin-induced diabetes. Can J Physiol Pharmacol 75:781-788, 1997
12. Irlbeck M, Zimmer H-G: Functional responses of the left and right heart of diabetic rats to α- and β-adrenergic receptor stimulation. Diabetes Res Clin Pract 31:S79-S86, 1996
13. Berridge M: Inositol trisphosphate and calcium signalling. Nature 361:315-325, 1993
14. 2+ and pH in isolated rabbit hearts and myocytes loaded with the indicator indo-1. J Physiol 480:203-215, 1994
15. 2+ mobilization in adult rat cardiomyocytes by angiotensin type 1 and 2 receptors. Biochem Pharmacol 55:1413-1418, 1998
16. Hunton DL, Lucchesi PA, Pang Y, Cheng X, Dell'Italia LJ, Marchase RB: Capacitative calcium entry contributes to NFAT nuclear translocation. J Biol Chem 277:14266-14273, 2002
17. Hunton DL, Zou LY, Pang Y, Marchase RB: Adult rat cardiomyocytes exhibit capacitative calcium entry. Am J Physiol 286:H1124-H1132, 2004
18. Putney JWJ: Capacitative Calcium Entry. Austin, Landes Biomedical, 1997
19. Trepakova ES, Csutora P, Hunton DL, Marchase RB, Cohen RA, Bolotina VM: Calcium influx factor directly activates store-operated cation channels in vascular smooth muscle cells. J Biol Chem 275:26158-26163, 2000
20. 2+ entry into mouse skeletal muscle fibres. J Physiol (Lond) 533:185-199, 2001
21. Vandebrouck C, Martin D, Schoor MC, Debaix H, Gailly P: Involvement of TRPC in the abnormal calcium influx observed in dystrophic (mdx) mouse skeletal muscle fibers. J Cell Biol 158:1089-1096, 2002
22. Pang Y, Hunton DL, Bounelis P, Marchase RB: Hyperglycemia inhibits capacitative calcium entry and hypertrophy in neonatal cardiomyocytes. Diabetes 51:3461-3467, 2002
23. Marshall S, Bacote V, Traxinger RR: Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system: role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266:4706-4712, 1991
24. Austin CE, Chess-Williams R: Transient elevation of cardiac beta-adrenoceptor responsiveness and receptor number in the streptozotocin-diabetic rat. J Auton Pharmacol 12:205-214, 1992
25. D'Amico M, Marfella R, Nappo F, Di Filippo C, De Angelis L, Berrino L, Rossi F, Giugliano D: High glucose induces ventricular instability and increases vasomotor tone in rats. Diabetologia 44:464-470, 2001
26. Robinson KA, Weinstein ML, Lindenmayer GE, Buse MG: Effects of diabetes and hyperglycemia on the hexosamine synthesis pathway in rat muscle and liver. Diabetes 44:1438-1446, 1995
27. Barrett AM: Cardiac beta-adrenoceptor blockade: the quest for selectivity. J Pharmacol 16 (Suppl. 2):95-108, 1985
28. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820, 2001
29. 2+ exchange in rat ventricular myocytes. Cardiovasc Res 38:703-710, 1998
30. 2+ exchange in cells expressing NCX1. J Biol Chem 271:22391-22397, 1996
31. Mizock BA: Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab 15:533-551, 2001
32. Putney JW Jr, Ribeiro CM: Signaling pathways between the plasma membrane and endoplasmic reticulum calcium stores. Cell Mol Life Sci 57:1272-1286, 2000
33. Chen H, Li D, Saldeen T, Mehta JL: TGF-beta 1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregulation of MMP-1. Am J Physiol 284:H1612-H1617, 2003
34. Chen S, Hong SW, Iglesias-de la Cruz MC, Isono M, Casaretto A, Ziyadeh FN: The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy. Ren Fail 23:471-481, 2001
35. Schaffer SW, Croft CB, Solodushko V: Cardioprotective effect of chronic hyperglycemia: effect on hypoxia-induced apoptosis and necrosis. Am J Physiol 278:H1948-H1954, 2000
36. Piper HM, Meuter K, Schafer C: Cellular mechanisms of ischemia-reperfusion injury. Ann Thorac Surg 75:S644-S648, 2003
37. Ziegelhoffer A, Styk J, Ravinegerova T, Sebokova J, Volkovova K, Waczulikova I, Carsky J, Turecky L: Mechanisms that may be involved in calcium tolerance of the diabetic heart. Mol Cell Biochem 176:191-198, 1997
38. Zimmerman AN, Hulsmann WC: Paradoxical influence of calcium ions on the permeability of the cell membranes of the isolated rat heart. Nature 211:646-647, 1966
39. 2+ load in neonatal cardiac cell culture. Biophys J 76:2649-2663, 1999
40. Langer GA: Excitation-contraction coupling and calcium compartmentation. In The Myocardium. 2nd ed. Langer GA, Ed. San Diego, CA, Academic, 1997, p. 181-233
41. Haq S, Choukroun G, Lim H, Tymitz KM, del Monte F, Gwathmey J, Grazette L, Michael A, Hajjar R, Force T, Molkentin JD: Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure. Circulation 103:670-677, 2001
42. 2+, calcineurin, and NF-AT. Cell 96:611-614, 1999
43. Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, Brownlee M: Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A 97:12222-12226, 2000
44. Hresko RC, Heimberg H, Chi MM-Y, Mueckler M: Glucosamine-induced insulin resistance in 3T3-L1 adipocytes is caused by depletion of intracellular ATP. J Biol Chem 273:20658-20668, 1998
45. Nelson BA, Robinson KA, Buse MG: High glucose and glucosamine induce insulin resistance via different mechanisms in 3T3-L1 adipocytes. Diabetes 49:981-991, 2000
46. Wells L, Vosseller K, Hart GW: Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science 291:2376-2378, 2001
47. Kreppel LK, Hart GW: Regulation of a cytosolic and nuclear O-GlcNAc transferase: role of the tetratricopeptide repeats. J Biol Chem 274:32015-32022, 1999
48. Walgren JL, Vincent TS, Schey KL, Buse MG: High glucose and insulin promote O-GlcNAc modification of proteins, including alpha-tubulin. Am J Physiol 284:E424-E434, 2003
49. Palmer BM, Olsson MC, Lynch JM, Mace LC, Snyder SM, Valent S, Moore RL: Chronic run training suppresses alpha-adrenergic response of rat cardiomyocytes and isovolumic left ventricle. Am J Physiol 277:H2136-H2144, 1999
50. Woodman OL, Vatner SF: Cardiovascular responses to the stimulation of alpha-1 and alpha-2 adrenoceptors in the conscious dog. J Pharmacol Exp Ther 237:86-91, 1986
51. Hilal-Dandan R, Kanter JR, Brunton LL: Characterization of G-protein signaling in ventricular myocytes from the adult mouse heart: differences from the rat. J Mol Cell Cardiol 32:1211-1221, 2000